Regenexx Corporate Revenue and Competitors

Regenexx was the first to use stem cells to treat orthopedic injuries, and we've published roughly half of all worldwide research in their application. With more than 2.5 million covered lives across the country, Regenexx uses our advanced regenerative technologies to help self-funded employers save 80% on their orthopedic healthcare costs by providing an effective, low-cost alternative to roughly 70% of orthopedic surgeries. When given the choice between a Regenexx procedure and orthopedic surgery, 99% of employees choose Regenexx. The Regenexx process of treating musculoskeletal conditions involves a high level of physician skill and our patented, research-based protocols that allow us to realize outcomes that can only be achieved through our high standards of practice. We license our patented Interventional Orthopedics procedures to physicians across the country who are part of the Regenexx network. These expert physicians receive intensive initial and ongoing training and support. We additionally offer a one-year fellowship in Interventional Orthopedics. Learn more about Regenexx and how we can help you take control of your health care spend. Visit www.RegenexxCorporate.com for more information.